2-Bromo-11-methyl-7-(5-methyl-isoxazol-3-yl)-8H-4b,6,10,12-tetraaza-dibenzo[e,g]Azulene | 476364-21-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯氮卓类
• 英文名称: 2-Bromo-11-methyl-7-(5-methyl-isoxazol-3-yl)-8H-4b,6,10,12-tetraaza-dibenzo[e,g]Azulene
• 英文别名: 3-(16-bromo-11-methyl-2,4,10,12-tetrazatetracyclo[12.4.0.02,6.08,13]octadeca-1(14),3,5,8,10,12,15,17-octaen-5-yl)-5-methyl-1,2-oxazole
• CAS: 476364-21-3
• 化学式: C₁₉H₁₄BrN₅O
• 分子量: 408.257
• InChiKey: KBIIIERUASACRK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  26
• 可旋转键数：
  1
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.16
• 拓扑面积：
  69.6
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  10-Bromo-5,7-dihydro-2-methyl-6H-pyrimido[5,4-d][1 ]benzazepin-6-one 、 n,n-Dimethyl-n'-(5-methyl-isoxazol-3-ylmethyl)-formamidine 生成 2-Bromo-11-methyl-7-(5-methyl-isoxazol-3-yl)-8H-4b,6,10,12-tetraaza-dibenzo[e,g]Azulene
  参考文献：
  名称：

  Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives

  摘要：

  本发明涉及一种化合物，其化学式为1，其中R1为卤素或较低烷基；R2为氢、较低烷基、环烷基、-(CH2)m-苯基，其中苯环可以被较低烷氧基取代，或为-(CH2)m-吲哚基；R3为-C（O）O-较低烷基、-C（O）OH或五元杂环芳基，这些环可以被较低烷基或环烷基取代；n为0、1或2；m为0、1或2；或其药学上可接受的酸加成盐。化合物I显示出对GALA A &agr;5受体结合位点的高亲和力和选择性。

  公开号：

  US20030055042A1

文献信息

• Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
  申请人：——

  公开号：US20030055042A1

  公开（公告）日：2003-03-20

  The present invention is a compound of formula 1 wherein R 1 is halogen or lower alkyl; R 2 is hydrogen, lower alkyl, cycloalkyl, —(CH 2 ) m -phenyl, wherein the phenyl ring may be substituted by lower alkoxy, or is —(CH 2 ) m -indolyl; R 3 is —C(O)O-lower alkyl, —C(O)OH, or a five membered heteroaromatic group, which rings may be substituted by lower alkyl or cycloalkyl; n is 0, 1 or 2; m is 0, 1 or 2; or a pharmaceutically acceptable acid addition salt thereof. Compound I shows high affinity and selectivity for GALA A &agr;5 receptor binding sites.

  本发明是一种化合物，其化学式为 1 其中 R 1 是卤素或较低的烷基; R 2 是氢、较低的烷基、环烷基、—(CH 2 ) m -苯基，其中苯环可能被较低的烷氧基取代，或者是—(CH 2 ) m -吲哚基; R 3 是—C(O)O-较低的烷基、—C(O)OH，或者是一个五元杂环芳基，这些环可能被较低的烷基或环烷基取代; n为0、1或2; m为0、1或2; 或其药学上可接受的酸盐。化合物I显示出对GALA A &agr;5受体结合位点的高亲和力和选择性。
• Amino-substituted dihydropyrimido[4,5-D]pyrimidinone derivatives
  申请人：——

  公开号：US20040087600A1

  公开（公告）日：2004-05-06

  Compounds of formula I 1 are described. These compounds are protein kinase inhibitors, in particular they inhibit the src family tyrosine kinases. Thus, these compounds are useful for the treatment of diseases mediated by src tyrosine kinases, including cell proliferative disorders such as cancer. Also described are methods of making and using compounds of formula I as well as pharmaceutical compositions containing these compounds.

  描述了化学式I1的化合物。这些化合物是蛋白激酶抑制剂，特别是它们抑制src家族酪氨酸激酶。因此，这些化合物对于治疗由src酪氨酸激酶介导的疾病，包括癌症等细胞增殖性疾病，具有用途。还描述了制备和使用化学式I的化合物的方法，以及含有这些化合物的药物组合物。
• IMIDAZO 1,5-A] PYRIMIDO 5,4-D] BENZAZEPINE DERIVATIVES AS GABA A RECEPTOR MODULATORS
  申请人：F. Hoffmann-La Roche AG

  公开号：EP1399448B1

  公开（公告）日：2004-12-01
• US6686352B2
  申请人：——

  公开号：US6686352B2

  公开（公告）日：2004-02-03
• [EN] IMIDAZO [1,5-A] PYRIMIDO [5,4-D] BENZAZEPINE DERIVATIVES AS GABA A RECEPTOR MODULATORS<br/>[FR] DERIVES D'IMIDAZO [1,5-A] PYRIMIDO [5,4-D] BENZAZEPINE EN TANT QUE MODULATEURS DU RECEPTEUR GABA A
  申请人：HOFFMANN LA ROCHE

  公开号：WO2002094834A1

  公开（公告）日：2002-11-28

  The present invention relates to compounds of formula (I) wherein R1 is halogen or lower alkyl; R2 is hydrogen, lower alkyl, cycloalkyl, -(CH¿2?)m-phenyl, wherein the phenyl ring may be substituted by lower alkoxy, or is (CH2)m-indolyl; R?3¿ is C(O)O-lower alkyl, -C(O)OH, or a five membered heteroaromatic group, which rings may be substituted by lower alkyl or cycloalkyl; n is 0, 1 or 2 ; m is 0, 1 or 2 ; and their pharmaceutically acceptable acid addition salts. It has been found that this class of compounds show high affinity and selectivity for GABA A α5 receptor binding sites and might be useful for the treatment of cognitive enhancer or of cognitive disorders like Alzheimer's disease.